Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain

Neuroscience Letters

Volumn 221, Issue 1, 1996, Pages 17-20

  Takeda, Akinori ^a,b   Yasuda, Takeshi ^a   Miyata, Toshio ^a   Mizuno, Keiko ^a   Li, Mei ^a   Yoneyama, Sakae ^b   Horie, Katsunori ^a   Maeda, Kenji ^a   Gen Sobue, ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Oyamada Memorial Spa Hospital   (Japan)

Author keywords

amyloid protein; advanced glycation end products; aging; Alzheimer's disease; neuron

Indexed keywords

AMYLOID BETA PROTEIN;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLYCATION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SENILE PLAQUE;

ADOLESCENT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN CHEMISTRY; GLYCOSYLATION END PRODUCTS, ADVANCED; HIPPOCAMPUS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MUSCULAR DYSTROPHIES; PYRAMIDAL CELLS; RABBITS;

EID: 0030604239     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)13275-4     Document Type: Article

References (22)

1. Araki, N., Ueno, N., Chakrabarti, B., Morino, Y. and Horiuchi, S., Immunohistochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging, J. Biol. Chem., 267 (1992) 10211-10214.
2. Baynes, J.W., Perspectives in diabetes. Role of oxidative stress in development of complications in diabetes, Diabetes, 40 (1991) 405-412.
3. Brownlee, M., Cerami, A. and Vlassara, H., Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications, N. Engl. J. Med., 318 (1988) 1315-1321.
4. Dyer, D.G., Dunn, J.A., Thorpe, S.R., Bailie, K.E., Lyons, T.J., McCance, D.R. and Baynes, J.W., Accumulation of Maillard reaction products in skin collagen in diabetes and aging, J. Clin. Invest., 91 (1993) 2463-2469.
5. Exley, C., Schley, L., Murray, S., Hackney, C.M. and Birchall, J.D., Aluminium, β-amyloid and non-enzymatic glycosylation, FEBS Lett., 364 (1995) 182-184.
6. Harrington, C.R. and Colaco, C.A.L., A glycation connection, Nature, 370 (1994) 247-249.
7. Jiang, Z.Y., Woollard, A.C.S. and Wolff, S.P., Hyrdogen peroxide production during experimental protein glycation, FEBS Lett., 268 (1990) 69-71.
8. Kimura, T., Takamatsu, J., Araki, N., Goto, M., Kondo, A., Miyakawa, T. and Horiuchi, S., Are advanced glycation end-products associated with amyloidosis in Alzheimer's disease?, NeuroReport, 6 (1995) 866-868.
9. Kimura, T., Takamatsu, J., Ikeda, K., Kondo, A., Miyakawa, T. and Horiuchi, S., Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons, Neurosci. Lett., 208 (1996) 53-56.
10. Ledesma, M.D., Bonay, P. and Avila, J., B-protein from Alzheimer's disease patients is glycated at its tubulin-binding domain, J. Neurochem., 65 (1995) 1658-1664.
11. Li, J.J., Voisin, D., Quiquerez, A.-L. and Bouras, C., Differential expression of advanced glycosylation end-products in neurons of different species, Brain Res., 641 (1994) 285-288.
12. Li, J.J., Surini, M., Catsicas, S., Kawashima, R. and Bouras, C., Age-dependent accumulation of advanced glycosylation end products in human neurons, Neurobiol. Aging, 16 (1995) 69-76.
13. Miyata, T., Oda, O., Inagi, R., Iida, Y., Araki, N., Yamada, N., Horiuchi, S., Taniguchi, N., Maeda, K. and Kinoshita, T., β2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis, J. Clin. Invest., 92 (1993) 1243-1252.
14. Miyata, T., Taneda, S., Kawai, R., Ueda, Y., Horiuchi, S., Hara, M., Maeda, K. and Monnier, V.M., Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin-containing amyloid fibrils in patients with dialysis related amyloidosis, Proc. Natl. Acad. Sci. USA, 93 (1996) 2353-2358.
15. Miyata, T., Iida, Y., Ueda, Y., Shinzato, T., Seo, H., Monnier, V.M. and Maeda, K., Monocyte/macrophage response to β2-microglobulin modified with the advanced glycation end products, Kidney Int., 49 (1996) 538-550.
16. Monnier, V.M., Nonenzymatic glycosylation, the Maillard reaction and the aging process, J. Gerotol., 45 (1990) B105-B111.
17. ε-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins, Biochemistry, 34 (1995) 10872-10878.
18. Sakurai, T. and Tsuchiya, S., Superoxide production from nonenzymatically glycated protein, FEBS Lett., 236 (1988) 406-410.
19. Slight, S.H., Feather, M.S. and Ortwerth, B.J., Glycation of lens proteins by the oxidation products of ascorbic acid, Biochim. Biophys. Acta, 1038 (1990) 367-374.
20. Smith, M.A., Taneda, S., Richey, P.I., Miyata, S., Yan, S.D., Stern, D., Sayre, L.M., Monnier, V.N. and Perry, G., Advanced Maillard reaction end products are associated with Alzheimer disease pathology, Proc. Natl. Acad. Sci. USA, 91 (1994) 5710-5714.
21. Vitek, M.P., Bhattacharya, K., Glendening, M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K. and Cerami, A., Advanced glycation end products contribute to amyloidosis in Alzheimer disease, Proc. Natl. Acad. Sci. USA, 91 (1994) 4766-4770.
22. Yan, S.D., Chen, X., Schmidt, A.M., Brett, J., Godman, G., Zou, Y.S., Scott, C.W., Caputo, C., Frappier, T., Smith, M.A., Perry, G., Yen, S.H. and Stern, D., Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress, Proc. Natl. Acad. Sci. USA, 91 (1994) 7787-7791.